Cargando…

Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries

OBJECTIVES: A centralised approach to health technology assessment (HTA) may facilitate optimal use of HTA resources. A regional approach may increase the chances of local implementation of recommendations. This study aimed to compare assessment procedures in England (centralised HTA approach) with...

Descripción completa

Detalles Bibliográficos
Autores principales: Corbacho, B., Drummond, M., Santos, R., Jones, E., Borràs, J. M., Mestre-Ferrandiz, J., Espín, J., Henry, N., Prat, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214388/
https://www.ncbi.nlm.nih.gov/pubmed/32026155
http://dx.doi.org/10.1007/s10198-020-01160-5
_version_ 1783531959484416000
author Corbacho, B.
Drummond, M.
Santos, R.
Jones, E.
Borràs, J. M.
Mestre-Ferrandiz, J.
Espín, J.
Henry, N.
Prat, A.
author_facet Corbacho, B.
Drummond, M.
Santos, R.
Jones, E.
Borràs, J. M.
Mestre-Ferrandiz, J.
Espín, J.
Henry, N.
Prat, A.
author_sort Corbacho, B.
collection PubMed
description OBJECTIVES: A centralised approach to health technology assessment (HTA) may facilitate optimal use of HTA resources. A regional approach may increase the chances of local implementation of recommendations. This study aimed to compare assessment procedures in England (centralised HTA approach) with Spain (regional HTA approach) discussing key challenges and opportunities from both approaches. METHODS: We compared technology assessments of anticancer medicines in the two jurisdictions from 2008 to 2015. To assess the implementation of HTA recommendations, we assessed trends in medicine usage using regression methods. We used IQVIA data, from 2011 to 2016, for a sample of 11 medicines. We used CatSalut data from Catalonia to assess the implementation of local recommendations. RESULTS: In England, 66 assessments were undertaken by the National Institute for Health and Care Excellence (NICE), using a standardised methodology. In Spain, there were 79 reports undertaken by a range of bodies using a shared process and coordinated through the GENESIS collaboration; the assessment methods used varied substantially. Overall, the recommendations in the two jurisdictions were similar. Regression analyses indicate that where there is a positive recommendation by HTA bodies, the usage of the medicine responds most strongly (p < 0.001) in Catalonia (4.892), followed by England (3.120) and Spain (1.693). CONCLUSIONS: This study suggests that medicine utilisation does respond to the positive recommendations of HTA bodies. However, if HTA capacity is organised primarily regionally, considerable effort may be required in coordination, to ensure consistent and rigorous assessments and adequate implementation of HTA findings. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10198-020-01160-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7214388
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-72143882020-05-14 Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries Corbacho, B. Drummond, M. Santos, R. Jones, E. Borràs, J. M. Mestre-Ferrandiz, J. Espín, J. Henry, N. Prat, A. Eur J Health Econ Original Paper OBJECTIVES: A centralised approach to health technology assessment (HTA) may facilitate optimal use of HTA resources. A regional approach may increase the chances of local implementation of recommendations. This study aimed to compare assessment procedures in England (centralised HTA approach) with Spain (regional HTA approach) discussing key challenges and opportunities from both approaches. METHODS: We compared technology assessments of anticancer medicines in the two jurisdictions from 2008 to 2015. To assess the implementation of HTA recommendations, we assessed trends in medicine usage using regression methods. We used IQVIA data, from 2011 to 2016, for a sample of 11 medicines. We used CatSalut data from Catalonia to assess the implementation of local recommendations. RESULTS: In England, 66 assessments were undertaken by the National Institute for Health and Care Excellence (NICE), using a standardised methodology. In Spain, there were 79 reports undertaken by a range of bodies using a shared process and coordinated through the GENESIS collaboration; the assessment methods used varied substantially. Overall, the recommendations in the two jurisdictions were similar. Regression analyses indicate that where there is a positive recommendation by HTA bodies, the usage of the medicine responds most strongly (p < 0.001) in Catalonia (4.892), followed by England (3.120) and Spain (1.693). CONCLUSIONS: This study suggests that medicine utilisation does respond to the positive recommendations of HTA bodies. However, if HTA capacity is organised primarily regionally, considerable effort may be required in coordination, to ensure consistent and rigorous assessments and adequate implementation of HTA findings. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10198-020-01160-5) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-02-05 2020 /pmc/articles/PMC7214388/ /pubmed/32026155 http://dx.doi.org/10.1007/s10198-020-01160-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Paper
Corbacho, B.
Drummond, M.
Santos, R.
Jones, E.
Borràs, J. M.
Mestre-Ferrandiz, J.
Espín, J.
Henry, N.
Prat, A.
Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries
title Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries
title_full Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries
title_fullStr Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries
title_full_unstemmed Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries
title_short Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries
title_sort does the use of health technology assessment have an impact on the utilisation of health care resources? evidence from two european countries
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214388/
https://www.ncbi.nlm.nih.gov/pubmed/32026155
http://dx.doi.org/10.1007/s10198-020-01160-5
work_keys_str_mv AT corbachob doestheuseofhealthtechnologyassessmenthaveanimpactontheutilisationofhealthcareresourcesevidencefromtwoeuropeancountries
AT drummondm doestheuseofhealthtechnologyassessmenthaveanimpactontheutilisationofhealthcareresourcesevidencefromtwoeuropeancountries
AT santosr doestheuseofhealthtechnologyassessmenthaveanimpactontheutilisationofhealthcareresourcesevidencefromtwoeuropeancountries
AT jonese doestheuseofhealthtechnologyassessmenthaveanimpactontheutilisationofhealthcareresourcesevidencefromtwoeuropeancountries
AT borrasjm doestheuseofhealthtechnologyassessmenthaveanimpactontheutilisationofhealthcareresourcesevidencefromtwoeuropeancountries
AT mestreferrandizj doestheuseofhealthtechnologyassessmenthaveanimpactontheutilisationofhealthcareresourcesevidencefromtwoeuropeancountries
AT espinj doestheuseofhealthtechnologyassessmenthaveanimpactontheutilisationofhealthcareresourcesevidencefromtwoeuropeancountries
AT henryn doestheuseofhealthtechnologyassessmenthaveanimpactontheutilisationofhealthcareresourcesevidencefromtwoeuropeancountries
AT prata doestheuseofhealthtechnologyassessmenthaveanimpactontheutilisationofhealthcareresourcesevidencefromtwoeuropeancountries